Barr Premarin Petition On Misleading Labeling May Be Renewed; ANDA Planned

Barr will decide by the end of January whether to continue to pursue its citizen petition claiming that labeling for Wyeth-Ayerst's Premarin (conjugated estrogens) is false and misleading